The Global Heart Foundation is an initiative : To Raise Awareness about Heart Diseases Globally I Education of HCPs I Public Health Campaign. #GHFHeart
Patients w/ overweight or obesity, diabetes, & #HFpEF prescribed #SGLT2 inhibitors experienced reduced risk of HF exacerbations, hospitalizations, & ED visits w/ addition of GLP-1 RA.
Read the journal scan to learn more: https://t.co/JDJe1emBOL #JACCHF#HeartFailure
#ACCEd on AFib & Antiarrhythmic Drugs is tailored to keep you on the leading edge of #AFib management. Check out the new infographic 👇 & the other FREE activities, including a quick tips video, patient cases, & an ACC CardiaCast podcast.
Learn more: https://t.co/CQJ3gm1rrD
Empower yourself by Joining our Post ESC and EASD 2024 Spotlight Session for Free organized by the CRM Academy.
• 2 Hrs of CME Points
Thursday 14 November 2024 at 6:45 PM (UK Time)
Register Now: https://t.co/Gsw8TFcckU
Empower your patients to respond to #SuddenCardiacArrest
🩺 Know the warning signs
⚡ Act fast—every minute counts
💓 Take a CPR class or refresh your skills
📍 Learn how to use an AED and know where to find one
📢 Make sure to share #CardioSmart materials 👇 with your patients! https://t.co/DpOrWxduFY #SCA #SCAMonth
About 2 in 5 adults in the U.S. have high cholesterol.
Use ACC's #CardioSmart tools and resources to educate your patients on all aspects of cholesterol. https://t.co/pNpWXtonk8 #CholesterolEducationMonth
Heart failure with preserved ejection fraction: underdiagnosed and undertreated in patients with tricuspid regurgitation. Read this viewpoint in #EHJ 👉 https://t.co/GjgjHRbPF2
@RoccoMontone@ehj_ed
Quintuple Therapy for deteriorating HF Patients.
#Vericiguat : A potential Quintuple Therapy drug💊 with proven clinical benefits in “VICTORIA Trial”
📍Vericiguat associated with 🔻risk of CV death or HF hospitalisation in patient with high risk HF
In patients with obesity undergoing electrical cardioversion for AFib, dual direct-current cardioversion (DCCV) results in greater cardioversion success compared with single DCCV. https://t.co/6xDYv3Xs4z @OchsnerCardio@OchsnerEp@OchsnerHealth@danielpmorin
A study recently published in #JACC found risk estimation for coronary heart disease at the population level was not enhanced by correcting LDL-C for its content of lipoprotein(a).
Read more: https://t.co/33I05aL8oY
Original Article: Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA) https://t.co/sAyCiZkZLH
Editorial: Entering a New Era in Sleep-Apnea Treatment https://t.co/uu5ImeLA3k
#ADASciSessions
Become a Member of the
GHA Network 🌐
Membership is free for : Doctors, Pharmacists, Nurses & HCPs.
Join now for free.🆓
https://t.co/BboFJRRs5Q
Get free access to several courses with CPD & CME points.
#GhaHealth#GHA_NETWORK#doctors#membership#Free#nurses#hospitals